• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科药物——市售口服制剂综述

Pediatric drugs--a review of commercially available oral formulations.

作者信息

Strickley Robert G, Iwata Quynh, Wu Sylvia, Dahl Terrence C

机构信息

Formulation and Process Development, Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California 94404, USA.

出版信息

J Pharm Sci. 2008 May;97(5):1731-74. doi: 10.1002/jps.21101.

DOI:10.1002/jps.21101
PMID:17823956
Abstract

Pediatric oral formulations can be quite scientifically challenging to develop and the prerequisites for both a measurable dosage form to administer based upon bodyweight, and also taste-masking are two of the challenges unique for pediatric oral formulations. The physicochemical and organoleptic properties of the active drug substance such as solubility, chemical stability, and taste along with the intended dose can determine which formulations are feasible to develop. Oral pediatric formulations are available in 17 different varieties and can be either a ready-to-use formulation such as a solution, syrup, suspension, tablet, scored tablet, chewable tablet, orally disintegrating tablet, or thin strip, or can also be a formulation that requires manipulation such as a powder for constitution to a suspension, tablet for constitution to a suspension, powder for constitution to a solution, drops for reconstitution to a suspension, concentrated solution for dilution, effervescent tablet, bulk oral granules, bulk oral powder, or solid in a capsule to mix with food or drink. Recently there has been an increase in pediatric formulation development inspired by increased regulatory incentives. The intent of this review is to educate the reader on the various types of formulations administered orally to pediatrics, the rationale in deciding which type of formulation to develop, the excipients used, development challenges, the in-use handling of oral pediatric formulations, and the regulatory incentives.

摘要

儿科口服制剂的研发在科学上颇具挑战性,基于体重给药的可测量剂型以及掩味是儿科口服制剂独有的两大挑战。活性药物成分的物理化学和感官特性,如溶解度、化学稳定性和味道,以及预期剂量,可决定哪些制剂在研发上是可行的。儿科口服制剂有17种不同类型,既可以是即用型制剂,如溶液剂、糖浆剂、混悬剂、片剂、刻痕片、咀嚼片、口腔崩解片或细条剂,也可以是需要调配的制剂,如用于配制成混悬剂的粉末、用于配制成混悬剂的片剂、用于配制成溶液的粉末、用于复溶成混悬剂的滴剂、用于稀释的浓溶液、泡腾片、口服散剂、口服散粒剂或与食物或饮料混合的胶囊剂。最近,受监管激励措施增加的影响,儿科制剂的研发有所增加。本综述的目的是让读者了解儿科口服的各类制剂、决定研发哪种制剂的依据、所用辅料、研发挑战、儿科口服制剂的使用处理以及监管激励措施。

相似文献

1
Pediatric drugs--a review of commercially available oral formulations.儿科药物——市售口服制剂综述
J Pharm Sci. 2008 May;97(5):1731-74. doi: 10.1002/jps.21101.
2
Pediatric Oral Formulations: An Updated Review of Commercially Available Pediatric Oral Formulations Since 2007.儿科口服制剂:自 2007 年以来市售儿科口服制剂的更新综述。
J Pharm Sci. 2019 Apr;108(4):1335-1365. doi: 10.1016/j.xphs.2018.11.013. Epub 2018 Nov 14.
3
Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.用于儿科和老年患者的口服柔性片剂(OFT)制剂的开发:一种新型的适合年龄的制剂平台。
AAPS PharmSciTech. 2017 Aug;18(6):1972-1986. doi: 10.1208/s12249-016-0666-0. Epub 2016 Dec 5.
4
Primary packaging considerations in developing medicines for children: oral liquid and powder for constitution.儿童用药研发中的初级包装考量:口服液体制剂和散剂(供制成溶液)
J Pharm Sci. 2015 Jan;104(1):52-62. doi: 10.1002/jps.24223. Epub 2014 Nov 12.
5
Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.400毫克阿昔洛韦的两种口服混悬剂和两种口服片剂剂型的生物利用度:在健康墨西哥成年受试者中进行的两项单剂量、开放标签、随机、两期交叉比较。
Clin Ther. 2007 Jun;29(6):1146-52. doi: 10.1016/j.clinthera.2007.06.007.
6
Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.卡托普利速释口崩片替代制剂与口服液体制剂的稳定性比较。
Clin Ther. 2012 Nov;34(11):2221-9. doi: 10.1016/j.clinthera.2012.10.005.
7
A new esomeprazole packet (sachet) formulation for suspension: in vitro characteristics and comparative pharmacokinetics versus intact capsules/tablets in healthy volunteers.一种用于混悬液的新型埃索美拉唑包装(小袋)制剂:健康志愿者体内的体外特性及与完整胶囊/片剂的药代动力学对比
Clin Ther. 2007 Apr;29(4):640-9. doi: 10.1016/j.clinthera.2007.03.014.
8
Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.随机试验中口服溶液与普通片的双氯芬酸钾的药代动力学差异:进食与禁食状态的影响。
Headache. 2015 Feb;55(2):265-75. doi: 10.1111/head.12483. Epub 2014 Dec 24.
9
Methods of administering oral formulations and child acceptability.口服制剂的给药方法及儿童接受度。
Int J Pharm. 2015 Aug 1;491(1-2):261-7. doi: 10.1016/j.ijpharm.2015.06.047. Epub 2015 Jul 2.
10
Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.两种萘普生钠/对乙酰氨基酚口服片剂和两种口服混悬剂的生物利用度:在健康墨西哥成年受试者中进行的单剂量、随机、开放标签、两阶段交叉比较。
Clin Ther. 2009 Feb;31(2):399-410. doi: 10.1016/j.clinthera.2009.02.002.

引用本文的文献

1
Taste Masking of Steroids for Oral Formulations.口服制剂中甾体药物的掩味
Turk J Pharm Sci. 2024 Jan 19;20(6):352-360. doi: 10.4274/tjps.galenos.2023.24968.
2
Colour of Medicines and Children's Acceptability? A Systematic Literature Review of Children's Perceptions about Colours of Oral Dosage Forms.药品颜色与儿童接受度?关于儿童对口服剂型颜色认知的系统文献综述
Pharmaceutics. 2023 Jul 20;15(7):1992. doi: 10.3390/pharmaceutics15071992.
3
Innovations in Chewable Formulations: The Novelty and Applications of 3D Printing in Drug Product Design.
咀嚼片剂型的创新:3D打印在药品设计中的新颖性及应用
Pharmaceutics. 2022 Aug 18;14(8):1732. doi: 10.3390/pharmaceutics14081732.
4
Neoteric Approach of Fluoxetine Laden Orodispersible Film for Non-compliant Pediatric Patients of Selective Mutism and Obsessive-compulsive Disorder.氟西汀口腔崩解膜治疗选择性缄默症和强迫症不依从儿科患者的新方法。
Turk J Pharm Sci. 2021 Dec 31;18(6):683-694. doi: 10.4274/tjps.galenos.2021.23080.
5
3D Printing of Thermo-Sensitive Drugs.热敏药物的3D打印
Pharmaceutics. 2021 Sep 21;13(9):1524. doi: 10.3390/pharmaceutics13091524.
6
Current Status of Pediatric Formulations for Chronic and Acute Children' Diseases: Applications and Future Perspectives.儿童急慢性疾病儿科制剂的现状:应用与未来展望
Medeni Med J. 2021;36(2):152-162. doi: 10.5222/MMJ.2021.78476. Epub 2021 Jun 18.
7
3D Printing of Mini Tablets for Pediatric Use.用于儿科的迷你片剂的3D打印
Pharmaceuticals (Basel). 2021 Feb 11;14(2):143. doi: 10.3390/ph14020143.
8
I Spy with My Little Eye: A Paediatric Visual Preferences Survey of 3D Printed Tablets.我用我的小眼睛发现:一项关于3D打印平板电脑的儿科视觉偏好调查。
Pharmaceutics. 2020 Nov 17;12(11):1100. doi: 10.3390/pharmaceutics12111100.
9
Sprinkle formulations-A review of commercially available products.散剂剂型——市售产品综述
Asian J Pharm Sci. 2020 May;15(3):292-310. doi: 10.1016/j.ajps.2019.05.003. Epub 2019 Jul 8.
10
Co-administration of Paediatric Medicines with Food and Drinks in the Context of Their Physicochemical Properties-a Global Perspective on Practices and Recommendations.儿科药物在其理化性质方面与食物和饮料共同给药-全球范围内的实践和建议。
AAPS J. 2020 Mar 4;22(2):54. doi: 10.1208/s12248-020-0432-9.